Skip to main content

Table 3 Univariate- and multivariate analysis with respect to disease-free survival in 239 all breast cancers

From: Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer

Parameter Univariate analysis Multivariate analysis
Hazard ratio 95% CI p value Hazard ratio 95% CI p value
   all breast cancers (n = 239)
Age ≤56 1.434 0.808–2.574 0.218    
Menopause Pre 1.149 0.637–2.040 0.639    
Tumor size (cm) > 2 1.799 0.728–5.979 0.223    
Lymph node status Positive 2.494 1.143–6.550 0.020 2.826 1.281–7.474 0.008
Nuclear grade 3 1.086 0.510–2.103 0.819    
Ki67 (%) ≤14 1.717 0.959–3.052 0.069    
Intrinsic subtype TNBC 1.015 0.542–1.828 0.962    
Pathological response non-pCR 1.965 1.050–3.948 0.034 1.693 0.861–3.514 0.129
LMR Low 2.318 1.285–4.350 0.005 2.245 1.237–4.233 0.008
NLR High 1.680 0.884–3.465 0.116    
  1. TNBC triple-negative breast cancer, pCR pathological complete response, NLR neutrophil-to-lymphocyte ratio, LMR lymphocyte-to-monocyte ratio, CI confidence interval